{"nctId":"NCT03697811","briefTitle":"DE-117 Spectrum 5 Study","startDateStruct":{"date":"2018-09-27","type":"ACTUAL"},"conditions":["Primary Open-angle Glaucoma and Ocular Hypertension"],"count":107,"armGroups":[{"label":"DE-117 Ophthalmic Solution 0.002%","type":"EXPERIMENTAL","interventionNames":["Drug: DE-117 Ophthalmic Solution"]}],"interventions":[{"name":"DE-117 Ophthalmic Solution","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patients with Primary Open-Angle Glaucoma or Ocular Hypertension in one or both eyes.\n* Provide signed written informed consent.\n* Diagnosis of POAG or OHT in both eyes.\n* Qualifying corrected visual acuity in each eye.\n* Qualifying central corneal thickness in each eye.\n* Qualifying Day 1 IOP measurement at 3 time-points in both eyes after latanoprost Run-in Period.\n* Qualifying Anterior chamber angle.\n* Qualifying IOP measurement at 3 time-points during latanoprost Run-in Period.\n\nExclusion Criteria:\n\n* Patients who cannot safely discontinue use of Ocular Hypotensive Medications during Washout.\n* Patients with prior exposure to DE-117.\n* History of ocular surgery specifically intended to lower IOP\n* Advanced glaucoma in either eye.\n* Any corneal abnormality or other condition interfering with or preventing reliable Goldmann applanation tonometry.\n* Any ocular surgery or ocular laser treatment within 180 days prior to Visit 1 (Screening) and throughout the study in either eye.\n* Females who are pregnant, nursing, or planning a pregnancy.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change From Baseline in Mean Diurnal Intraocular Pressure (IOP) at Month 3.","description":"IOP lowering effect of DE-117 ophthalmic solution 0.002% in Latanoprost low/non-responder subjects. Mean Diurnal Intraocular Pressure: Analysis of Change from Baseline in IOP score at Month 3 using Paired T-test on Observed Case. Mean Diurnal IOP is defined as the average IOP of all three timepoints (8:00,12:00, 16:00) at Month 3.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.96","spread":"2.831"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Mean Diurnal IOP at Week 2, Week 6 and Month 3","description":"The secondary efficacy endpoint evaluated percent change from baseline in mean DIOP at week 2, 6 and month 3.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-12.21","spread":"10.855"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-12.40","spread":"11.218"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-12.57","spread":"11.907"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Mean Diurnal IOP at Week 2 and Week 6","description":"Change from baseline (Visit 4) in mean diurnal IOP at Week 2 (Visit 5) and Week 6 (Visit 6).","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.87","spread":"2.531"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.89","spread":"2.578"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in IOP at Timepoints at Week 2","description":"Change in mean IOP were evaluated at each time point at all post-baseline visits. (Change from baseline measurement at each timepoint was calculated by deducting the baseline value at corresponding timepoint from the IOP measurement).","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.52","spread":"2.976"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.94","spread":"2.922"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.15","spread":"3.077"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in IOP at Timepoints at Week 6","description":"Change in mean IOP were evaluated at each time point at all post-baseline visits.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.42","spread":"3.209"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.86","spread":"2.832"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.44","spread":"3.127"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in IOP at Timepoints at Month 3","description":"Change in mean IOP were evaluated at each time point at all post-baseline visits.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.76","spread":"3.180"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.98","spread":"3.200"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.08","spread":"3.186"}]}]}]},{"type":"SECONDARY","title":"Intraocular Pressure: Percent Change From Baseline by Analysis Visit and Timepoint at Week 2","description":"Intraocular Pressure: Percent Change from Baseline by Analysis Visit and Timepoint.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-10.42","spread":"12.509"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-12.51","spread":"12.765"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-13.47","spread":"13.204"}]}]}]},{"type":"SECONDARY","title":"Intraocular Pressure: Percent Change From Baseline by Analysis Visit and Timepoint at Week 6","description":"Intraocular Pressure: Percent Change from Baseline by Analysis Visit and Timepoint.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-10.04","spread":"13.653"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-12.22","spread":"12.432"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-14.80","spread":"13.482"}]}]}]},{"type":"SECONDARY","title":"Intraocular Pressure: Percent Change From Baseline by Analysis Visit and Timepoint at Month 3","description":"Intraocular Pressure: Percent Change from Baseline by Analysis Visit and Timepoint.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-11.43","spread":"13.133"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-12.72","spread":"13.467"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-13.13","spread":"13.309"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":107},"commonTop":["Conjunctival hyperaemia","Punctate keratitis","Eye pain","Anterior chamber cell","Conjunctival oedema"]}}}